Rushin Desai

Biopharmaceuticals in India: Introduction, Growth and Swot Analysis of Biopharmaceuticals in India Rushin Desai

Biopharmaceutics is the field of study concerning biopharmaceuticals, medical drugs produced using biotechnology. They include proteins including antibodies, nucleic acids , DNA, RNA or antisense oligonucleotides and living microorganisms like virus and bacteria where the virulence of viruses and bacteria is reduced by the process of attenuation, they can be used for therapeutic or in vivo diagnostic purposes, and are produced by means other than direct extraction from a native biological source. India?s biopharmaceutical industry which was quite modest only a decade ago, is expected to generate almost $2 billion in sales in 2008, making it one of the largest biopharmaceutical segments in Asia.1 According to the Society for Industrial Microbiology?s newly published study, Advances in Biopharmaceutical Technology in India (BioPlan Associates, Inc., Rockville, MD), the Indian biopharmaceutical industry is growing 25 to 30% per year Export sales of Indian biopharmaceutical products are currently rising at an annual rate of 47%, while domestic sales of Indian biopharmaceutical products have risen only 4?5% per annum for each of the past two years. The value of India?s biopharmaceutical.